BBLG

NASDAQ 已收盘

Bone Biologics Corporation

0.95 USD
+0.05+5.01%
盘后 0.92 +2.77%
2026-08-03
市值
$1.70M
市盈率
EPS
-1.92
股息率
52 周区间
0.83 – 4.13
成交量
98.65K
Beta
0.53
目标价
52W 低 0.8352W 高 4.13
价格走势

公司简介

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or b...